 |
| PROGRAMME : DAY1 : DAY2 : DAY3 |
|
 |
7.30 - 8.15 |
Registration |
8.15 - 8.30 |
Opening ceremony |
| 8.30-9.00 |
 |
PMCT Research Linkages to Care and Treatment
Jeffrey Stringer
Professor of Obstetrics and Gynecology, University of Alabama; Director, Centre for Infectious
Disease Research in Zambia Lusaka, Zambia |
| 9.00-9.30 |
 |
Nucleoside analogues: Old friends or new enemies?
David Cooper
Scientia Professor of Medicine, University of New South Wales; Director, NCHECR Sydney,
Australia; Co-director, HIV-NAT
|
| 9.30-10.00 |
 |
Practical guide to selecting second line therapy in
resource
limited settings
Julian Elliott
Head of Clinical Research, Infectious Diseases Unit, Alfred Hospitaland HIV Clinical Advisor,
Burnet Institute. Melbourne, Australia
|
| 10.00- 10.30 |
COFFEE BREAK |
| 10.30-11.00 |
 |
HIV and adolescents
Helen Rees
Executive Director Reproductive Health and HIV Research Unit University of the Witwatersrand,
South Africa |
| 11.00-11.30 |
 |
d4T Keep it or abandon it?
Andrew Hill
Visiting Senior Research Fellow, Liverpool University, UK
|
| 11.30-12.00 |
 |
Antiretroviral therapy for children
Thanyawee Puthanakit
Associate Professor Division of Infectious Diseases, Department of Pediatrics, Faculty of
Medicine, Chulalongkorn University, Thailand. |
| 12.00- 13.30 |
Satelite Lunch Symposium by BMS |
| 13.30-16.00 |
Concurrent Workshops
|
Opportunistic infection
and IRIS
( Workshop 1 : Ballroom )
|
|
Adverse events in IDU patients :
Patrick Mallon
NCHECR, University of New South Wale
|
Peniciliosis :
Thuy Le
Assistant Professor of Medicine, University
of Hawaii
|
Cryptococcus IRIS :
Ploenchan Chetchotsakd
Professor of Medicine, Faculty of Medicine, khon Kaen University
|
Skin IRIS :
Nittaya Phanuphak
Program Cooridantor, TRCARC, Deputy Chief, SEARCH
|
Autoimmune IRIS :
Weerapan Khovidhunkit
Associate Professor of Medicine,
Chulalongkorn University
|
| |
| |
| |
|
| |
|
Paediatric HIV
( Workshop 2 : Meeting room 3)
|
|
Moderators :
Chitsanu Pancharoen
Associate Professor of Pediatrics,
Chulalongkorn University
Thanyawee Puthanakit
Associate Professor of Pediatrics,
Chulalongkorn University
|
HAART in infant born to mother without prenatal care :
Wasana Prasitsuebsai
MD, HIV-NAT
|
Treatment of infant exposed to single dose nevirapine :
Nia Kurniati
MD, Indonesia
|
First line therapy failure with tuberculosis :
Pope Kosalaraksa
Associate Professor of Pediatrics,
Faculty of Medicine, Khon Kaen Universtiy
|
Second line therapy failure :
Kulkanya Chokephaibulkit
Professor of Pediatrics,
Faculty of Medicine, Mahidol University
|
Adolescent: treatment and social issues :
Rawiwan Hansudewechakul
MD, Chieng Rai Hospital
|
|
| |
|
Drug Resistance
( Workshop 3 : Meeting room 1-2)
|
|
Moderators :
Kiat Ruxrungtham
Professor of Medicine,Faculty of Medicine,
Chulalongkorn University; Deputy director,
HIV-NAT
|
Baseline resistance testing :
Somnuek Sungkanuparph
Associate Professor of Medicine, Ramathibodi Hospital, Mahidol University
|
Monitoring and definition for failure :
Chris Duncombe
MD, HIV-NAT
|
First line failure :
Somnuek Sungkanuparph
Associate Professor of Medicine, Ramathibodi Hospital, Mahidol University
|
Second line failure :
Mark Boyd
MD, University of New South Wales, Australia
|
Treatment failure with tuberculorin:
Weerawat Manosutthi
MD, Department of Medicine, Bamrasnaradura infectious Diseases Institute
|
Drug interaction in salvage therapy :
David Burger
Professor of clinical Pharmacology,
Radboud University of Nijmegen Medical Center,
the Netherlands
|
|
| |
|
|
16.00 - 17.30 |
Satellite Symposium “ New Developments in HIV Therapy : Addressing unmet medical needs and enhancing care ”
by MSD Thailand at Ball room |
17.30 - 18.30 |
Cocktail by MSD Thailand, Reception Hall A
Moderator: Professor Emeritus Praphan Phanuphak
Title: New Developments in HIVTherapy: ASolution for Unmet Medical Needs
Emerging Roles of Integrase Inhibitor in HIVCare: A Global Perspective
Speaker: Associate Professor Somnuek Sungkanuparph
Role of Raltegravir in Resources-limitedSettings: ThailandExperiences
Speaker: Associate Professor Winai Ratanasuwan
Update of Clinical Research on Raltegravir:Current Understanding and Future Possibilities
Speaker: Charles Farthing, M.D.
|
|
|
 |
|
| |
|
Copyright 2007 Hivnat. All rights reserved.
|
|
